DSM

Company Snapshot

Founded: 1902
Entity Type: Public
Employees: 18855
Region: Rest of Europe Middle East and Africa (EMEA)
Revenue: $8,209.1 Millions
Revenue Year: 2023
Headquarter: The Netherlands
Key Geographics: North America, Latin America, Netherlands, Switzerland, China, Rest of Asia, Rest of Europe, Middle East and Africa
Corporate Address: Het Overloon 1 6411 TE Heerlen The Netherlands Tel: +31-45-578-2864 Web: www.dsm.com

Company Overview

DSM has established its headquarters in the Netherlands and is focused on biomedical solutions in the global market. The company offers various biomaterials in the global market, namely, hydrophilic coatings, medical polyurethanes, natural biomaterials, polyethylenes and sustained drug delivery. The company operates through its three major segments, namely, animal nutrition & health, health, nutrition & care and food & beverage. DSM has strong R&D activities in the polymer business. The company developed PEA-based biodegradable polymers specifically for drug delivery applications. The company has established its sales and service offices in the Netherlands, Switzerland, North America, Latin America, China and other countries.

Financial Highlights (FY 2023)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

DSM In Reports

The Global Market for Food Additives

BCC Research Market Analyst says global market for food additives is expected to grow from $80.4 billion in 2024 and is projected to reach $106.8 billion by the end of 2029, at a CAGR of 5.8%.

Biodegradable Polymers: Global Markets and Technologies

BCC Research Market Analyst says global market volumes of biodegradable polymers is expected to grow from 1,286.0 kilotons in 2023 and is projected to reach 4,140.0 kilotons by the end of 2028 at a CAGR of 26.3%.

Top Ten Suppliers of Synthetic Biology Technology

BCC Research Market Analyst says global market for synthetic biology is expected to increase from $35.5 billion in 2023 to $59.2 billion by the end of 2028, with a CAGR of 10.8%.

Company's Business Segments

  • Taste, Texture & Health - DSM : This segment provides Ingredients Solutions business.
  • Health, Nutrition & Care - DSM : This segment comprises the company’s former Health, Nutrition, and care business, including the Personal Care and Aroma Ingredients business.
  • Animal Nutrition & Health : This segment provides healthy animal proteins and helps to make animal farming practices more sustainable, productive, and transparent.
  • Corporate Activities : It includes corporate operating and service activities that are not further allocated to the operating segments.

Applications/End User Industries

  • Human Nutrition
  • Animal Nutrition
  • Health
  • Food and Beverage
  • Care & Health